2005
DOI: 10.1016/j.vaccine.2005.05.027
|View full text |Cite
|
Sign up to set email alerts
|

Induction of CD8+ T cell responses by Yersinia vaccine carrier strains

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
20
1

Year Published

2006
2006
2021
2021

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 24 publications
(21 citation statements)
references
References 52 publications
0
20
1
Order By: Relevance
“…Cellular immunity plays an important role in protection against pneumonic plague (45,46,(85)(86)(87)(88). To stimulate cellular immunity, heterologous antigens fused with YopE (aa 1 to 138) allow the chimeric protein to be specifically transported via the T3SS of live attenuated Y. pseudotuberculosis strains to become accessible to the major histocompatibility complex (MHC) class I-restricted antigenprocessing pathways and stimulate an antigen-specific cellular immune response (40,41). Thus, we constructed plasmid vectors containing the secretion and translocation signals of the Yersinia T3SS YopE effector protein, which are specified by the first 138 amino acids in the amino-terminal region of YopE (designated YopE Nt138 ).…”
Section: Constructionmentioning
confidence: 99%
See 1 more Smart Citation
“…Cellular immunity plays an important role in protection against pneumonic plague (45,46,(85)(86)(87)(88). To stimulate cellular immunity, heterologous antigens fused with YopE (aa 1 to 138) allow the chimeric protein to be specifically transported via the T3SS of live attenuated Y. pseudotuberculosis strains to become accessible to the major histocompatibility complex (MHC) class I-restricted antigenprocessing pathways and stimulate an antigen-specific cellular immune response (40,41). Thus, we constructed plasmid vectors containing the secretion and translocation signals of the Yersinia T3SS YopE effector protein, which are specified by the first 138 amino acids in the amino-terminal region of YopE (designated YopE Nt138 ).…”
Section: Constructionmentioning
confidence: 99%
“…Previous studies suggest that Y. pseudotuberculosis is a promising candidate for an oral live carrier vaccine, capable of stimulating antigen specific CD8 ϩ T-cell responses (40,41). Additionally, delivery of heterologous antigens by the type III secretion system (T3SS) in Y. pseudotuberculosis and Salmonella stimulated antigen-specific cytotoxic T-cell responses, antigen-specific CD8 ϩ memory T cells, and protection against challenge with different pathogens (40,42,43).…”
mentioning
confidence: 99%
“…YopP inhibited the CD8 T cell response to YopE-LLO in mice orally infected with Y. enterocolitica, an activity that could be correlated with the killing of APCs by this effector (56). In contrast, YopE was important for a maximal CD8 T cell response to Y. enterocolitica expressing YopE-LLO or YopE-OVA, most likely because this effector was required for bacterial colonization of deep murine lymphatic tissues such as spleen (30,58,61).…”
mentioning
confidence: 99%
“…In addition, the T3SS has been exploited for delivery of heterologous antigens by live attenuated Yersinia carrier vaccines (3,32,55,62,65,67,70). Evidence was obtained that YopP inhibited CD8 T-cell priming to a heterologous antigen in mice infected with a Y. enterocolitica carrier vaccine strain (32,65,67).…”
mentioning
confidence: 99%